FIELD: medicine, narcology.
SUBSTANCE: the method includes incubation of analyzed sample of blood serum with a conjugate hapten - macromolecular carrier immobilized upon a solid phase followed by incubation of developed immune complex with a conjugate of antibodies against enzyme-labeled human immunoglobulins M and G, and detection of the level of specific antibodies by the difference of optic density values of analyzed sample against analogous values of standard ones both with and without narcotic substances contained in blood serum followed by establishing the fact for the intake of narcotic substances in case of coincidence or prevailing the level of antibodies in analyzed and standard samples. The method deals with applying a conjugate, where hapten is being a derivative of metabolite of analyzed narcotic substance, and molecular carrier has been chosen out of the row of poly- or oligoacrylates, ovalbumin and lysozyme, at the ratio of hapten : macromolecular carrier in mol.% being (3-12):1. The method enables to detect increased number of persons with the intake of narcotic substances.
EFFECT: higher accuracy of diagnostics.
3 cl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EARLIER PREDICTING THE FACT OF THE INTAKE OF NARCOTIC SUBSTANCES AT THE ABSENCE OF CLINICAL SIGNS OF NARCOTIC ADDICTION | 2005 |
|
RU2296332C1 |
METHOD FOR DIAGNOSING NARCOTIC DRUG CONSUMPTION | 2005 |
|
RU2291436C1 |
SYNTHETIC IMMUNOGEN FOR PROTECTION AGAINST TOXIC ACTION OF NARCOTIC AND PSYCHOACTIVE SUBSTANCES | 2012 |
|
RU2526807C2 |
METHOD OF DETERMINING APTITUDE TO DISEASES OF DEPENDENCE | 2008 |
|
RU2369872C1 |
SYNTHETIC IMMUNOGEN FOR PROTECTION AND TREATMENT OF PSYCHOACTIVE SUBSTANCES ADDICTION | 2016 |
|
RU2643329C1 |
METHOD FOR DETERMINING NARCOTIC DRUGS IN HUMAN ORAL FLUID BY IMMUNOCHROMATOGRAPHY | 2010 |
|
RU2746467C1 |
METHOD FOR NARCOTIC SUBSTANCES DETERMINATION IN HUMAN ORAL FLUID USING THE IMMUNOCHROMATOGRAPHY | 2010 |
|
RU2442988C1 |
SYNTHETIC IMMUNOGEN FOR PROTECTION AND TREATMENT OF PSYCHOACTIVE SUBSTANCES ADDICTION | 2016 |
|
RU2635517C1 |
SYNTHETIC IMMUNOGEN FOR THERAPY AND PROPHYLAXIS OF ADDICTION WITH NARCOTIC AND PSYCHOACTIVE SUBSTANCES | 2003 |
|
RU2236257C1 |
IMMUNOGEN FOR TREATING AND PREVENTING OPIATE ADDICTION | 2013 |
|
RU2548802C1 |
Authors
Dates
2005-04-20—Published
2003-12-25—Filed